National Institute For Clinical Excellence Inquiry Into Beta Interferon

EDM number 899 in 1999-00, proposed by Robin Corbett on 27/06/2000.

That this House notes with concern that the National Institute for Clinical Excellence may recommend that beta interferon be denied to those people with MS who would benefit from it; recognises that significant numbers of people across the world have benefited from beta interferon; is aware that beta interferon is available in all other major European countries; and calls upon NICE to ensure this treatment is equitably available through the NHS.

This motion has been signed by a total of 60 MPs, 1 of these signatures have been withdrawn.